Frederick Hrkac - Feb 24, 2023 Form 4/A - Amendment Insider Report for BioSig Technologies, Inc. (BSGM)

Role: Director
Signature: /s/Kenneth Londoner, attorney-in-fact
Stock symbol: BSGM
Transactions as of: Feb 24, 2023
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 4/21/2023, 04:30 PM
Date Of Original Report: Feb 28, 2023
Previous filing: Nov 22, 2022
Next filing: Apr 21, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSGM	Common Stock	Award	$0	+16K	+35.2%	$0.00	61.5K	Feb 24, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of restricted stock were granted in lieu of remuneration for the Company's 2022 fourth quarter board fees and shall be fully vested as of February 24, 2023, the date of the grant, based on a closing price of $1.19 per share on such date.
F2	On February 28, 2023, the reporting person filed a Form 4 which inadvertently reported a grant of 12,000 shares of restricted stock in lieu of remuneration for the Company's 2022 fourth quarter board fees when in fact, as reported in this amendment, the reporting person was granted 16,000 shares of restricted stock, and therefore beneficially owned 61,455 shares following the reported transaction.

Content

The shares of restricted stock were granted in lieu of remuneration for the Company's 2022 fourth quarter board fees and shall be fully vested as of February 24, 2023, the date of the grant, based on a closing price of $1.19 per share on such date.

On February 28, 2023, the reporting person filed a Form 4 which inadvertently reported a grant of 12,000 shares of restricted stock in lieu of remuneration for the Company's 2022 fourth quarter board fees when in fact, as reported in this amendment, the reporting person was granted 16,000 shares of restricted stock, and therefore beneficially owned 61,455 shares following the reported transaction.